NEW YORK – Personalis said Wednesday that it has priced its recently announced public offering of 6,578,947 shares of its common stock at $19 per share. It expects gross proceeds to be about $125 million.
The company, which has commercialized a suite of next-generation sequencing services for population genomics and cancer diagnostics research, didn't detail its intended use of proceeds from the offering.
BofA Securities, Citigroup and Cowen are acting as joint book-running managers. BTIG, Needham & Company and Oppenheimer & Co. are acting as co-managers.
Personalis is also granting underwriters a 30-day option to purchase up to an additional 986,842 shares of common stock from a selling stockholder under the same terms and conditions. The firm will not receive any proceeds from the sale of shares by this other party.
The Menlo Park, California-based firm went public a little more than a year ago through a $155 million initial public offering.